- Home
- RCKT vs CNMD Comparison
RCKT vs CNMD Comparison
Compare RCKT & CNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RCKT | CNMD |
|---|---|---|
| Founded | 1999 | 1970 |
| Country | United States | United States |
| Employees | 202 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 534.2M | 1.2B |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | RCKT | CNMD |
|---|---|---|
| Price | $4.70 | $37.21 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 6 |
| Target Price | $29.65 | ★ $51.20 |
| AVG Volume (30 Days) | ★ 2.8M | 406.9K |
| Earning Date | 01-01-0001 | 04-27-2026 |
| Dividend Yield | N/A | ★ 1.09% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.51 |
| Revenue | N/A | ★ $1,374,724,000.00 |
| Revenue This Year | N/A | $0.82 |
| Revenue Next Year | $97.68 | $5.48 |
| P/E Ratio | ★ N/A | $24.32 |
| Revenue Growth | N/A | ★ 5.18 |
| 52 Week Low | $2.19 | $35.37 |
| 52 Week High | $8.80 | $62.41 |
Technical Indicators
Market Signals| Indicator | RCKT | CNMD |
|---|---|---|
| Relative Strength Index (RSI) | 56.97 | 29.93 |
| Support Level | $2.99 | $35.37 |
| Resistance Level | $5.34 | $46.08 |
| Average True Range (ATR) | 0.38 | 1.47 |
| MACD | 0.02 | -0.92 |
| Stochastic Oscillator | 47.90 | 8.79 |
Price Performance
Historical ComparisonAbout RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.
About CNMD CONMED Corporation
Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.